`
`
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`MYLAN PHARMACEUTICALS INC.,
`Petitioner,
`
`V.
`
`MERCK SHARP & DOHME CORP.
`
`Patent Owner.
`
`US. Patent No. 7,326,708 to Cypes et al.
`Issue Date: February 5, 2008
`Title: Phosphoric Acid Salt of a Dipeptidyl Peptidase-IV Inhibitor
`
`Inter Partes Review No.: IPR2020-00040
`
`PETITIONER’S POWER OF ATTORNEY
`
`Mail Stop “PA TENT BOARD”
`Patent Trial and Appeal Board
`US. Patent and Trademark Office
`
`PO. Box 1450
`
`Alexandria, VA 22313-1450
`
`US___140334392V3 391026-00257
`
`
`
`PETITIONER’S POWER OF ATTORNEY
`
`Pursuant to 37 C.F.R. § 42.10(b), Petitioner Mylan Pharmaceuticals Inc.,
`
`having a principal place of business at 781 Chestnut Ridge Road, Morgantown,
`
`WV, 26505, hereby appoints the following practitioners as its attorneys to transact
`
`all business in the United States Patent & Trademark Office Association with any
`
`inter partes review of US. Patent No 7,326,708:
`
`
`
`
`
` Lead Counsel I Back-up Counsel
`
`
`
`Jitendra Malik, Ph.D.
`Reg. No. 55,823
`Katten Muchin Rosenman LLP
`550 S. Tryon Street, Suite
`2900
`Charlotte, NC 28202-4213
`jitty.malik@katten.com
`
`Alissa M. Pacchioli
`Reg. No. 74,252
`alissa.pacchioli@katten.com
`
`Christopher W. West, Ph.D.
`Reg. No. 74,724
`christopher.west@katten.com
`
`Heike S. Radeke, Ph.D.
`
`Reg. No. 75,394
`Heike.Radeke@katten.com
`
`Katten Muchin Rosenman LLP
`
`550 S. Tryon Street, Suite 2900
`
`Charlotte, NC 28202-4213
`
`and all practitioners associated with Customer Number 27160.
`
`I have the authority to execute this document on behalf of Mylan
`
`Pharmaceuticals Inc.
`
`US_14O334392V3 391026-00257
`
`
`
`(—7
`[QM Q (“JCTAS
`
`:33. vx ((1.4 3
`Name??? W1
`Title: Am (,0 -- can-5A \v Lzh'sqkw
`Date: October 1+ ,2019
`
`US_140334392V3_391026-00257
`
`